Why consumer healthcare innovator Kenvue can come good for investors
Kenvue (KVUE:NYSE) $24.30Market cap: $46.6 billionInvestors looking to add a resilient company with healthy global growth potential to portfolios should consider Kenvue (KVUE:NYSE). The $46.6 billion cap stands behind a variety of...
05 December 2024